Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Finasteride helps protect brain in old male rats.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Spironolactone is effective and safe for treating hair loss, excessive hair growth, and acne.

Neurosteroids show promise for treating epilepsy and more research is needed.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

Women over forty can maintain skin and hair health with lifestyle and dietary changes.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Stress increases neurosteroids that help prevent seizures.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Facial dark spots can be caused by the sun, genetics, makeup, or medicine, and are diagnosed by patient history and skin tests.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.